• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

    Transitioning from Clinical Production to Commercial Manufacturing

    Clinical Trial Technology

    Regenerative Medicine: Overcoming the supply chain challenges

    The Future of the Pharmaceutical Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness

    Amgen Selects Location For R&D Facility

    Arctoris Opens Oxford R&D Facility

    Almac Group, Exostar Collaborate on IRT Experience

    Northwest Biotherapeutics Expands Management Team
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Amgen Selects Location For R&D Facility

    Catalent Launches Clinical Trial Planning Service

    CatSci Expands Capabilities with Lab Expansion

    PCI Pharma Services Invests in Tredegar, UK Site

    Avantor Boosts Biopharmaceutical Innovation in China
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Smart Tags on Pills Set to Improve Supply Chain Security and Patient Adherence

    Schreiner MediPharm, PragmatIC Form Partnership for Smart Pharma Labels

    Stevanato Group Begins Construction on TEC

    CSafe Global Expands Packaging Portfolio

    CSafe Global Opens Service Centers in Switzerland and Sweden
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness

    Amgen Selects Location For R&D Facility

    Arctoris Opens Oxford R&D Facility

    Almac Group, Exostar Collaborate on IRT Experience

    Charles River Provides Access to Cosmic Antibody Library
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pelican BioThermal Achieves ISO Accreditation

    PhRMA Appoints Federal Advocacy SVP

    CureVac Granted Mfg. Authorization for GMP Production Suite

    Metrics Completes Japanese Regulatory Inspection

    Samsung Biologics Achieves ISO27001 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    CCRM

    Jubilant HollisterStier Contract Manufacturing & Services

    Aphena Pharma Solutions, Inc.

    Flow Sciences, Inc.
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Vetter Pharma International GmbH

    CCRM

    Ajinomoto Bio-Pharma Services

    Aphena Pharma Solutions, Inc.

    Baxter BioPharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    CMAB Receives Positive Opinion Following External Quality Audit

    CDMO’s fully integrated facility in Suzhou, China was found to conform to EU Eudralex Vol. 4 GMP guidelines

    Related CONTENT
    • Pii Receives EIR From FDA
    • Flamma Completes Successful CFDA Inspection
    • Solid Dose Processing & Packaging Trends
    • Avid Bioservices, Inc.
    • Biotechpharma Expands Manufacturing Capacity
    09.10.19
    CMAB Biopharma (Suzhou) Inc., a pure-play contract development and manufacturing organization (CDMO) specializing in the production of mammalian cell-derived biologic products, received a positive opinion in an external European quality audit conducted by Parexel International Co.
     
    The purpose of the audit was to confirm that CMAB's quality standards are in line with European GMP, thereby verifying that its quality assurance and control systems can meet the requirements of development, production and testing of biologics for use as clinical investigational medicinal products (IMP) in Europe. The auditors conducted a comprehensive and thorough inspection of the company's quality systems, production and warehousing facilities, utilities and QC laboratory during the two day inspection, and gave a high appraisal of CMAB.
     
    As noted in the official report, "CMAB was observed to be a company with solid and sound business practices and quality focused goals and objectives. The commitment to quality and their business partners is clear and documented into all their system processes. The structure of their Quality Management System and the management commitment to quality is visible at all processes. The facilities were maintained, organized and functional and the company has knowledgeable and well trained staff."
     
    In addition, the report concluded that, "A comprehensive corporate Quality Management System based on the principles of GMP was in place. CMAB's premises and equipment were suitable and adequate to ensure proper manufacturing, storage, distribution as well as return and destruction activities of medicinal products used in clinical trials. Therefore, the overall impression of CMAB was positive and thus the drug manufacture and associated processes were considered GMP compliant and suitable for Parexel International Co.
     
    Also, CMAB was in compliance with EU Eudralex Volume 4 GMP for Medicinal Products for Human and Veterinary Use and fulfill the requirements for IMP EU import."
     
    "This result confirms our obligation to international partners and provides externally validated assurance that we conform to all the necessary infrastructure and policies in relation to the quality manufacturing of biologic products,” said Dr. Yongzhong Wang, chief executive officer, CMAB Biopharma. “I am immensely proud of the work and diligence that has gone into this review by our excellent quality team within CMAB, and indeed the wider organization, as we pass another milestone in our evolution towards being a fully integrated international CDMO."
     
    Michael Frizberg, president, CMAB Biopharma International, said, "Since founding CMAB Biopharma in July 2017, we have been entirely focused on meeting the stringent requirements of international biologics production and supply, so today's positive opinion is an incredibly important step in our brief history and we look forward to building more international partnerships."
    www.cmabbio.com/en
    Related Searches
    • Manufacturing
    • GMP
    • biologics
    • Biopharma
    Suggested For You
    Bora Secures FDA Approval for CDMO Services Bora Secures FDA Approval for CDMO Services
    Preparing for Your CDMO Selection Process Preparing for Your CDMO Selection Process
    CMAB and Kintor Enter Mfg. Tie-up CMAB and Kintor Enter Mfg. Tie-up
    CDMO Indena Improves Manufacturing Process CDMO Indena Improves Manufacturing Process
    Outsourcing in China: How far can it go? Outsourcing in China: How far can it go?
    Regis Technologies Expands Capabilities Regis Technologies Expands Capabilities
    Catching Up With Cambrex Catching Up With Cambrex
    Sterling’s Pilot Plant Facility Expansion is Operational Sterling’s Pilot Plant Facility Expansion is Operational
    Vetter Works Towards a Sustainable Energy Supply Vetter Works Towards a Sustainable Energy Supply
    Vibalogics Increases Capacity for Virus Manufacturing Vibalogics Increases Capacity for Virus Manufacturing
    The Biopharma Future The Biopharma Future
    IntelGenx to Promote Oral Films CDMO Services at CPhI North America IntelGenx to Promote Oral Films CDMO Services at CPhI North America
    Biotechpharma Expands Manufacturing Capacity Biotechpharma Expands Manufacturing Capacity
    Avid Bioservices, Inc. Avid Bioservices, Inc.
    Solid Dose Processing & Packaging Trends Solid Dose Processing & Packaging Trends

    Related Breaking News

    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      Sanofi Awarded $226M by US Gov

      Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness

      U.S.-based, state-of-the-art facilities to be established for sustainable production of adjuvanted recombinant vaccine for use in the event of a pandemic.
      Sanofi 12.13.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Avantor Boosts Biopharmaceutical Innovation in China

      Avantor Boosts Biopharmaceutical Innovation in China

      Opens innovation and customer support center in Shanghai.
      12.11.19

    • Biologics, Proteins, Vaccines | Breaking News | CRO News | Drug Discovery
      Charles River, Bit Bio Enter Strategic Pact

      Charles River, Bit Bio Enter Strategic Pact

      Partnership will leverage Bit Bio’s unique ability to generate authentic human cells at scale
      12.10.19


    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      Sanofi Pasteur Awarded HHS Pandemic Flu Vax Contract

      Sanofi Pasteur Awarded HHS Pandemic Flu Vax Contract

      To increase domestic pandemic influenza vaccine production capabilities in Swiftwater, PA
      12.09.19

    • Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News
      Sartorius Expands Cell Culture Media Capabilities

      Sartorius Expands Cell Culture Media Capabilities

      Pays $45 million for a majority stake in cell culture media specialist Biological Industries.
      12.09.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      WuXi Biologics Makes Second Major Investment in Ireland

      WuXi Biologics Makes Second Major Investment in Ireland

      To build a $240 million vaccine manufacturing facility on its Dundalk site.
      12.09.19


    • Biologics, Proteins, Vaccines | Breaking News | Industry News

      Novasep Launches oXYgene for Boosting Viral Vector Production

      A unique 2-year turnkey plant offer to accelerate commercial production of viral vectors.
      12.05.19

    • Aseptic Processing | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Polyplus-transfection Expands GMP Portfolio

      Polyplus-transfection Expands GMP Portfolio

      New GMP conditioning of PEIpro-GMP designed to support clinical phase and commercialization stages of production
      12.03.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
      3P Bio, In3Bio Enter Cancer Pact

      3P Bio, In3Bio Enter Cancer Pact

      New anti-tumor treatment is one step closer to the clinic on heels of new collaboration.
      11.28.19


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      Lonza and DiNAQOR AG Enter Gene Therapy Collaboration

      Lonza and DiNAQOR AG Enter Gene Therapy Collaboration

      Lonza’s manufacturing site in Houston, TX will handle all product supply for DiNA-001.
      11.28.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
      Novartis to Acquire The Medicines Company for $9.7B

      Novartis to Acquire The Medicines Company for $9.7B

      Adds cardiovascular drug inclisiran to portfolio, a potentially transformational investigational cholesterol-lowering therapy.
      11.28.19

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      WuXi Vaccines to Build a New Vaccine Mfg. Facility in Ireland

      WuXi Vaccines to Build a New Vaccine Mfg. Facility in Ireland

      Dedicated facility will supply a vaccine product of a large global pharma for the global market
      11.25.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      Navrogen, Lonza Enter Bio Production Deal

      Navrogen, Lonza Enter Bio Production Deal

      Sign agreement to use Lonza’s GS Gene Expression System for Navrogen’s anti-HIO targeting agents.
      11.22.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      HALIX Opens State-of-the-Art cGMP Facility

      HALIX Opens State-of-the-Art cGMP Facility

      New facility for the development and manufacturing of biopharmaceuticals.
      11.22.19

    • Biologics, Proteins, Vaccines | Breaking News | Industry News | Toxicology
      WuXi AppTec’s Lab Testing Division Expands in Suzhou

      WuXi AppTec’s Lab Testing Division Expands in Suzhou

      Increases toxicology capacity by 80% to execute full-service preclinical and clinical safety assessments for biologics and small molecules
      11.19.19

    Breaking News
    • Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    • Amgen Selects Location For R&D Facility
    • Arctoris Opens Oxford R&D Facility
    • Almac Group, Exostar Collaborate on IRT Experience
    • Northwest Biotherapeutics Expands Management Team
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI
    • Transitioning from Clinical Production to Commercial Manufacturing
    • Clinical Trial Technology
    • Regenerative Medicine: Overcoming the supply chain challenges
    • The Future of the Pharmaceutical Supply Chain
    • Challenges and Opportunities in Vaccines Drug Development
    • Managing Partnerships: Sponsors & CDMOs
    • Towards Sunset or a New Dawn?
    • Biopharma Over 20 Years
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.